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Continuous positive airway pressure
(CPAP) to treat respiratory distress
in newborns in low- and middle-income
countries
Juan Emmanuel Dewez1 and Nynke van den Broek2
Abstract
Severe respiratory distress is a serious complication common to the three major causes of neonatal mortality and
morbidity (prematurity, intra-partum-related hypoxia and infections). In low- and middle-income countries (LMICs), 20%
of babies presenting with severe respiratory distress die.
Continuous positive airway pressure (CPAP), is an effective intervention for respiratory distress in newborns and widely
used in high-income countries. Following the development of simple, safe and relatively inexpensive CPAP devices, there
is potential for large-scale implementation in the developing world.
In this article, we describe existing CPAP systems and present a review of the current literature examining the effect-
iveness of CPAP compared to standard care (oxygen) in newborns with respiratory distress. We also discuss the
evidence gap which needs to be addressed prior to its integration into health systems in LMICs.
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Introduction
An estimated 2.9million neonatal deaths occur each year,
the majority of which happen in developing countries.
Three main causes account for the majority of deaths:
prematurity (34%), intra-partum-related conditions
(25%) and infections (including pneumonia, 22%).1
Severe respiratory distress is a serious complication
which is common to these three main causes of neo-
natal death. In preterm newborns, respiratory distress
is predominantly secondary to a deﬁciency in surfac-
tant, a condition known as hyaline membrane disease
or respiratory distress syndrome (RDS). Other causes
are pneumonia, sepsis and pulmonary haemorrhage. In
term newborns, RDS, pneumonia, intra-partum-related
hypoxia and meconium aspiration syndrome are the
main causes of respiratory distress.2 The case fatality
rate for neonatal respiratory distress in LMICs can be
as high as 20%.3
Respiratory support to treat this condition is pro-
vided by CPAP or mechanical ventilation in high-
income countries.4 Surfactant is also used in newborns
presenting with RDS. However, the high cost and the
need for endotracheal intubation for its administration
makes surfactant unsuitable for low-resource settings
and in settings lacking medical staﬀ trained in endotra-
cheal intubation. Mechanical ventilation is expensive
and requires a high level of expertise. CPAP is the
only intervention which has the potential to be imple-
mented on a large scale in LMICs as simple, safe and
relatively inexpensive CPAP devices have been devel-
oped recently.3
Continuous positive airway
pressure (CPAP)
CPAP is a non-invasive type of respiratory support
which can be delivered without endotracheal intubation
although classical mechanical ventilators can also pro-
vide CPAP. It works by providing a continuous level of
positive pressure to the airways which distends the
lungs, overcomes collapse and improves ventilation.
CPAP can be generated in diﬀerent ways: (1) by using
a variable ﬂow of air and oxygen, toward the patient
during inhalation and away from the patient during
exhalation (variable ﬂow CPAP); (2) by blowing a
high ﬂow of air and oxygen (high ﬂow nasal cannula);
or (3) by immersing the end of a respiratory circuit and
making the patient exhale against a column of water,
generating bubbles (bubble CPAP)
Bubble CPAP is the method that is most adapted to
low-resources settings (Figure 1). Flow is generated by
a concentrator and delivered to the patient and exhaled
into a column of water. The length of the immersed
pipe determines the level of pressure. An opening
allows air to escape from the bottle. The air-oxygen
blender allows titration of oxygen. Bubble CPAP
devices are cheaper than variable ﬂow CPAP; some
use air and oxygen extracted from ambient air unlike
variable ﬂow CPAP which requires medical piped gas
systems or oxygen cylinders. These sources of air and
oxygen are often not available in hospitals in LMICs.
Finally, bubble CPAP provides a more stable level of
pressure compared to high ﬂow nasal cannula.
However, bubble CPAP does require a constant
Figure 1. Diagram of a bubble CPAP system.
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source of electricity which can be problematic in remote
facilities.3
It is possible to assemble a ‘homemade’ bubble
CPAP device by connecting nasal prongs to a source
of humidiﬁed oxygen and immersing the other extrem-
ity into a column of water. However, the gas ﬂow
needed to generate CPAP (i.e. 2–10L/min) may be
too high for the diameter of regular nasal prongs, gen-
erating too much resistance and failing to produce an
appropriate level of pressure. More importantly, such
systems do not oﬀer the possibility of titrating oxygen
because ‘homemade’ systems are not provided with air-
oxygen blenders. Therefore, there is a real risk of
delivering excess oxygen and causing retinopathy of pre-
maturity in preterm babies, a consequence of oxygen
toxicity which can lead to blindness.4 As such, commer-
cial bubble (or other) CPAP devices which can regulate
the oxygen dosage are preferable when treating preterm
babies, for example.
Effectiveness of CPAP
CPAP has been used for decades in high-income coun-
tries and a recent review has shown that the use of
oxygen and CPAP may have resulted in a 75% reduc-
tion in RDS-related mortality over the last century in
the United States.5 However, in LMICs, at the
moment, oxygen alone is often the only intervention
available to treat babies with respiratory distress.
A systematic review from the Cochrane collabor-
ation on the eﬀect of continuous distending pressure
(which includes CPAP and continuous negative pres-
sure, a technique which is no longer used in newborns)
compared to oxygen has shown that CPAP in preterm
infants with respiratory distress signiﬁcantly reduces
treatment failure (relative risk [RR], 0.61; 95% conﬁ-
dence interval [CI], 0.45–0.81). In addition, there was a
reduction in the need for additional mechanical venti-
lation (RR, 0.65; 95% CI, 0.47–0.89).6 With regards to
reduction in mortality, the review included two unpow-
ered trials (199 patients in total) from the US to
demonstrate the superiority of CPAP (RR, 0.52;
95% CI, 0.23–1.16). Even though the review showed
that continuous distending pressure (CPAP and/or
continuous negative pressure) reduces mortality in pre-
terms with respiratory distress (RR, 0.52; 95% CI,
0.32–087), the six trials included in this analysis were
all conducted in high-income countries.
Another recent review which examined the eﬀect of
CPAP in LMICs identiﬁed only one high quality ran-
domised controlled trial (RCT) comparing CPAP to
oxygen.7 The study was a multi-centre trial conducted
in 12 South American centres. The study showed that
the CPAP group required lower rates of additional
mechanical ventilation compared to the group receiving
oxygen only (29.8% vs. 50.4%, P¼ 0.001).8 However,
both groups received a co-intervention (surfactant)
which means that the results of this trial are not gener-
alisable to settings where surfactant is not available.
Moreover, some of the study sites (Chile and
Uruguay) are classiﬁed as high income countries by
the World Bank. Finally, the study was not suﬃciently
powered to show a diﬀerence in mortality rates.
Regarding adverse events, a common concern
among clinicians is the occurrence of pneumothorax.
None of the systematic reviews showed that CPAP sig-
niﬁcantly increases this risk. However, all these trials
were conducted in controlled settings with a high level
of monitoring.
Therefore, for LMICs, there is need for further
research to assess whether CPAP can be implemented
safely in a manner that consistently improves outcomes
for newborns, including a particular eﬀect on newborn
mortality.
Summary
Interest in using CPAP for newborns with respiratory
distress in LMICs has increased recently. It is a promis-
ing intervention but research to assess the feasibility of
its implementation in existing health systems of LMICs
is needed before implementation at scale. There is also a
need to study outcomes, including case fatality rates
and incidence of adverse events, in LMICs before and
after the introduction of CPAP.
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Neurological manifestations of scrub
typhus in adults
Abhinav Rana1, Sanjay K Mahajan2, Arindam Sharma1,
Sudhir Sharma3, Balbir S Verma4 and Ashok Sharma5
Abstract
In order to study the neurological manifestations in adult patients suffering from scrub typhus, 323 patients aged over 18
years, admitted with a positive diagnosis, were screened for neurological dysfunction; 37 patients with symptoms and/or
signs suggestive of neurological dysfunction were included in the study. Of these, 31 (84%) patients had altered sensor-
ium, four (11%) had cerebellitis, one (2%) patient had acute transverse myelitis and one (2%) had bilateral papilloedema
without focal neurological deficit. Of the 31 patients with altered sensorium, 15 (40%) had meningoencephalitis, three
(8%) had seizures, two (5%) had cerebral haemorrhages, one (2%) had a presentation likened to neuroleptic malignant
syndrome (NMS) and one (2%) had a 6th nerve palsy with inflammation of the right cavernous sinus. Cerebrospinal fluid
(CSF) analysis was abnormal in 23 patients (raised lymphocytes in 68%, raised protein in 80%). All patients improved with
anti-rickettsial therapy.
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Introduction
Scrub typhus is caused by Orientia tsutsugamushi. It is
transmitted to humans by the bite of larval stage (chig-
ger) of trombiculid mites. It is an acute, febrile, infec-
tious illness and is endemic to a part of the world
known as the ‘tsutsugamushi triangle’ which extends
from northern Japan and far-eastern Russia in the
north, to northern Australia in the south, and to
Pakistan and Afghanistan in the west.1
The disease is characterised by fever, headache,
myalgia, cough, injected conjunctiva and gastrointes-
tinal symptoms. An eschar at the site of the chigger
bite, regional lymphadenopathy and a maculopapular
rash may provide a clue to diagnosis. The disease is
characterised by focal or disseminated vasculitis and
perivasculitis which may involve the lungs, heart,
liver, spleen and central nervous system.1,2 Scrub
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